Responses
Colorectal
Case report
Evolving strategies to reduce colectomy rates in primary sclerosing cholangitis-inflammatory bowel disease: clinical remission of corticosteroid refractory colitis post-liver transplant with vedolizumab
Compose a Response to This Article
Other responses
No responses have been published for this article.